20.99k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
|Watchlist||Change today||1-month return||1-year return||Total return|
|The Fight Against COVID19||+5.45%||-||-||-|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|JNJ||Johnson & Johnson||170.22||+0.26||+0.15%||4:00 pm GMT-4||5.80M||7.64M||448.26B|
|PFE||Pfizer Inc.||40.02||-0.08||-0.20%||4:02 pm GMT-4||15.69M||30.11M||223.24B|
|ABBV||AbbVie Inc.||116.43||-0.17||-0.15%||4:02 pm GMT-4||6.05M||6.90M||205.64B|
|SNY||Sanofi||52.74||+0.20||+0.38%||4:00 pm GMT-4||1.39M||1.56M||130.99B|
|GSK||GlaxoSmithKline plc||39.08||+0.42||+1.09%||4:00 pm GMT-4||3.60M||5.48M||96.85B|
|GILD||Gilead Sciences, Inc.||68.53||-0.38||-0.55%||4:00 pm GMT-4||6.85M||7.78M||85.95B|
|MRNA||Moderna, Inc.||161.38||+11.51||+7.68%||4:00 pm GMT-4||6.51M||10.00M||64.80B|
|REGN||Regeneron Pharmaceuticals, Inc.||516.62||-0.55||-0.11%||4:00 pm GMT-4||785.75k||930.00k||55.04B|
|TAK||Takeda Pharmaceutical Company Limited||17.12||+0.18||+1.06%||4:00 pm GMT-4||1.87M||2.93M||53.83B|
|BNTX||BioNTech SE||192.77||+11.98||+6.63%||4:00 pm GMT-4||2.95M||2.64M||46.56B|
|NVAX||Novavax, Inc.||131.69||+10.69||+8.83%||4:00 pm GMT-4||4.24M||3.72M||9.76B|
|VIR||Vir Biotechnology, Inc.||42.21||+2.66||+6.73%||4:00 pm GMT-4||535.66k||1.16M||5.49B|
|INO||Inovio Pharmaceuticals, Inc.||6.55||+0.32||+5.14%||4:00 pm GMT-4||6.16M||10.68M||1.37B|
Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) are hoping to have an opportunity to win authorization for their COVID-19 vaccine in India. In this Motley Fool Live video recorded on May 5, Motley Fool contributors Keith Speights and Brian Orelli discuss just how big Pfizer's opportunity in India could be. Keith Speights: Pfizer ticker, there's P-F-E. Pfizer announced earlier this week that it's talking with the government of India about a potential accelerated pathway to authorization for its COVID-19 vaccine.
Of course, investors have another meaning in mind when they think about yield. Investors can at times feel like they have to give up a lot to gain a high dividend yield. Here are three high-yield dividend stocks I'd buy right now.
It’s a busier week ahead on the economic calendar. Private sector PMIs will draw plenty of interest late in the week. Geopolitics will also be in focus in the week.